Executive Team

September 10, 2020 Brendan Martin on the Pharmaphorum Podcast Alnylam’s Brendan Martin, Head of Europe, Middle East, Africa, and Canada and General Manager for the UK & Ireland, recently spoke on the Pharmaphorum podcast. Read More ›
August 6, 2020 Alnylam Promotes Dr. Yvonne Greenstreet to President & COO Dr. Yvonne Greenstreet, has been elevated to the role of President of Alnylam. She will retain her COO role as well. Read More ›
June 9, 2020 John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Lin ... In a new e-book, dozens of biopharma industry leaders, including our CEO John Maraganore, share their perspectives from the industry's unique vantage point... Read More ›
May 1, 2020 John Maraganore on the "I Am BIO" Podcast: Destroying COVID's Genome Our CEO John Maraganore recently spoke with Biotechnology Innovation Organization (BIO) CEO and Chairman Jim Greenwood on the "I Am BIO" podcast. Read More ›
November 18, 2019 Building a Culture of Passion and Commitment Kelley Boucher, SVP/Chief Human Resources Officer, discusses Alnylam being named to The Boston Globe's 2019 Best Places to Work List... Read More ›
November 5, 2019 A Truly Special Place for Science Recently, our company was named Science Magazine’s Top Employer for 2019 – a significant achievement in the scientific community and a true milestone... Read More ›
September 17, 2019 +MyFamily Program with 23andMe Aims to Increase Awareness of TTR-Related Hereditary Amyloi ... hATTR amyloidosis is a potentially devastating and life-threatening condition that may affect families, generation after generation. Read More ›
September 2, 2019 ORION-11: A Landmark Event for RNAi Therapeutics The results from the ORION-11 Phase 3 study of inclisiran, presented earlier today at the European Society of Cardiology meeting represent a landmark event... Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site